Business
Update on proposed Share Reorganisation
Update on proposed Share Reorganisation.
About this update from Cambridge Nutritional Sciences Plc
[{"type":"text","content":"\n\nOmega Diagnostics Group plc\n('Omega' or the 'Company')\n \nUpdate on proposed Share Reorganisation\n \nOmega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, announces an update with regards its proposed Share Reorganisation as notified in the Company's Notice of Annual General Meeting, which was posted to shareholders on 11 August 2023.\n \nProposed Share Reorganisation\n \nHaving consulted with a number of shareholders post the announcement of 31 August, the board has decided not to proceed with the proposed Share Reorganisation and associated consolidation of the Ordinary Shares. The board will withdraw Resolution 8 set out in the Notice of AGM with regards the Share Reorganisation.\n \nAccordingly, the issued share capital of the Company will remain unchanged at 237,685,180 ordinary shares of 4 pence each and 123,245,615 deferred shares of 0.9 pence each.\n \nThe Company remains well funded and the Directors reiterate that they have no need or intention to raise funds at this time.\n \nContacts: \n \n\n\n\nOmega Diagnostics Group PLC \n\n\nwww.omegadx.com\n\n\n\n\nJag Grewal, Chief Executive Officer \n\n\nvia Walbrook PR\n\n\n\n\n\n\n\n\n\n\n\n\nfinnCap Ltd \n\n\nTel: 020 7220 0500\n\n\n\n\nGeoff Nash / Edward Whiley / George Dollemore (Corporate Finance)\n\n\n\n\n\n\n\nNigel Birks / Harriet Ward (ECM)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Limited\n\n\nTel: 020 7933 8780 or [email protected]\n\n\n\n\nPaul McManus / Lianne Applegarth\n\n\nMob: 07980 541 893 / 07584 391 303\n\n\n\n\nSam Allen\n\n\nMob: 07502 558 258\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \nAbout Omega Diagnostics Group PLC\nOmega (AIM: ODX) is a specia...